The oncogenic lncRNAs lncARSR [52], TUG1 [67], URRCC [90], FGD5-AS1 [109], LINC00982, DUXAP9 [110], DLEU1 [111], LUKAT1 [112], MALAT1 [113], and HOTTIP [114] are described as activators of the PI3K/AKT/mTOR pathway in RCC. This evidence concerns the gene MTOR and renal cell carcinoma.